Although much is known about transcriptional networks that control embryonic stem cell (ESC) self-renewal and differentiation, the metabolic regulation of ESC is less clear. Autophagy is a catabolic process that is activated under both stress and normal conditions to degrade damaged organelles and aggregated proteins, and thus plays pivotal roles in somatic and adult stem cell function. However, if and how ESCs harness autophagy to regulate stemness remains largely unknown. Recently, we have defined that autophagy is essential for mitochondrial homeostasis regulation in pluripotency acquirement and maintenance. Here we identified high autophagic flux as an essential mechanism to maintain ESC identity. We show that mouse ESCs exhibit a high autophagic flux that is maintained by coordinating expression of autophagy core molecular machinery genes through FOXO1, a forkhead family transcription factor. Tapering autophagic flux by manipulating either Atg3 or Foxo1 expression compromised ESC self-renewal, pluripotency, and differentiation that could be restored by gain of wild-type but not function-deficient Atg3 or Foxo1 mutants, respectively. Our results define a newly recognized role of autophagic flux in mouse ESC identity maintenance that links cellular catabolism to ESC fate regulation. Whereas much is known about the transcriptional networks controlling embryonic stem cell (ESC) self-renewal and differentiation activities, less is understood on metabolic regulation of ESCs. Macroautophagy (hereafter referred to autophagy) is a catabolic process wherein both organelles and proteins are degraded to maintain cellular homeostasis.
Whereas much is known about the transcriptional networks controlling embryonic stem cell (ESC) self-renewal and differentiation activities, less is understood on metabolic regulation of ESCs. Macroautophagy (hereafter referred to autophagy) is a catabolic process wherein both organelles and proteins are degraded to maintain cellular homeostasis. [1] [2] [3] The autophagy process is regulated by mTOR (mammalian target of rapamycin) and a set of autophagy-related genes. The mTOR, a serine/threonine protein kinase, negatively regulates autophagy by inhibitory phosphorylation of ULK1 (S757) and preventing formation of ULK1-ATG13-FIP200 complex (which is required for autophagy initiation) through mTOR complex 1 (mTORC1). [4] [5] [6] [7] Basal autophagy is required to metabolize cytoplasmic components and avoid accumulation of damaged proteins and organelles and plays important roles in mammalian differentiation and development. 8 Autophagy has been shown to play important roles in adult stem cells. For example, competent autophagy was demonstrated to protect hematopoietic stem cell from metabolic stress by a FOXO3A-driven pro-autophagy gene program. 9 In muscle stem cells, autophagy maintains stemness by preventing senescence. 10 Pluripotent stem cells (PSCs), including induced pluripotent and ESCs, hold great promise for regenerative medicine because of their ability to undergo unlimited self-renewal and retain pluripotency to differentiate into all cell types of the three germ layers. [11] [12] [13] [14] Recent studies have shown that both canonical and noncanonical autophagy plays important roles for reprogramming to pluripotency, indicating the potential involvement of autophagy for stemness regulation in ESCs. [15] [16] [17] Most recently, we have demonstrated that canonical autophagy regulates mitochondrial homeostasis in pluripotency acquirement and maintenance. At the same time we have provided evidences to show that canonical autophagy involves in mouse ESC self-renewal and pluripotency. 18 However, the characters of autophagy in ESC and how does autophagy regulate ESC stemness is largely unknown.
Results
PSCs have high autophagic flux. To investigate how autophagy regulates ESC identity, we first compared autophagic flux between somatic cells (mouse embryonic fibroblasts (MEFs); ESC-derived fibroblasts; ESC-derived neuron stem cells), ESCs, and MEF-derived iPSCs. Autophagic flux was determined by assaying LC3-II turnover in cells that were either untreated or treated with the autophagy inhibitor chloroquine (Supplementary Figure S1c) . Although MEFs have a higher LC3-II/LC3-I ratio than that of PSCs, the LC3-II enrichment extent in chloroquine-treated PSCs is significantly higher than that in somatic fibroblasts, indicating that PSCs have a higher basal autophagic flux (Figures 1a, b , and e and Supplementary Figures S1a and b) . Next, we tracked changes in autophagosome number and morphology using transmission electronic microscopy (TEM). Although the number of autophagosomes in PSCs was lower than that in MEFs (Figure 1c and Supplementary Figure S1d) , the increase of autophagosomes in PSCs upon chloroquine treatment is significantly higher than that of MEFs (Figure 1d) . Furthermore, the percentage of autophagy vacuole (AV) areas in PSCs upon chloroquine treatment is significantly higher than that of MEFs ( Supplementary  Figures S1e and f) . These results are consistent with western blot data ( Figure 1a) . We then investigated differences in autophagy induction in cells following starvation. The accumulation of LC3-II in PSCs was significantly higher than that of MEFs upon starvation treatment, indicating that PSCs have a powerful autophagic infrastructure that can provide enhanced autophagic potency upon induction (Figure 1f and Supplementary Figures S2a and b) .
Long-lived protein degradation is currently the most quantitative assay to determine autophagic flux, because it provides a precise numerical readout that reflects the fate of all long-lived cellular proteins but not a single autophagic substrate. 19 To further confirm the differential autophagic fluxes between PSCs and somatic cells, we measured the bulk degradation of long-lived proteins. Cellular proteins were labeled with 14 C for 24 h, followed by 1 h of incubation without 14 C-labeled amino acids to exclude short-lived radiolabeled proteins that are usually degraded by the proteasome. 20, 21 The cellular release of degraded proteins under the different treatment conditions was then quantified. In agreement with the high autophagic flux observed in PSCs, these cells have a significantly higher protein degradation rate relative to MEFs (Figure 1g ). With starvation treatment, the PSCs induced robust degradation of long-lived proteins with much faster dynamics than that of MEFs, in which degradation could be inhibited by 3-methyladenine (3-MA)/bafilomycin A1 (Baf-A1) treatment (Figure 1g and Supplementary Figure S2c) . Collectively, these data demonstrate that, compared with somatic fibroblasts, PSCs not only have a higher basal autophagic flux but also a higher potency for autophagy induction in response to stress.
High autophagic flux in PSCs is maintained by enhanced autophagy core machinery gene expression. To investigate the mechanisms by which PSCs maintain high autophagic flux and robust competency for autophagy induction, we next tested the activation status of mTORC1, the principal pathway that inhibits autophagy induction. 2, 22, 23 We saw no differences in mTORC1 activation between PSCs and MEFs, as detected by measuring levels of phosphorylated mTOR (p-mTOR) or phosphorylated p70S6K (p-p70S6K), the two direct targets of mTORC1 in autophagy regulation (Figure 2a ). These data indicate that the increased autophagic flux in PSCs is not due to differential mTORC1 activation between PSCs and somatic fibroblasts.
Autophagic flux is maintained by a core molecular machinery that is composed of an autophagy sensor system, induction complex, and an autophagosome formation system. 1, 3, 24 To investigate whether enhanced autophagic flux is due to the presence of a powerful autophagic infrastructure in PSCs, we analyzed existing transcriptome data and compared the expression of core molecular machinery genes between PSCs and somatic fibroblasts using 17 ESCs, 14 iPSCs, and 12 fibroblast-independent lines. 25 Approximately half of the analyzed genes were ubiquitously upregulated in both ESCs and iPSCs relative to somatic fibroblasts (Supplementary Table S1 ). Real-time quantitative RT-PCR was employed to verify these results (Figures 2b-f) . The significant enhancement of the expression of genes involved in the autophagy initiation ULK1 complex (Ulk1, Atg13, and Atg101), supports a more efficient isolation membrane elongation and/or closure existing in PSCs (Figure 2b) . Meanwhile, the expression of Pik3r4, Vps34, Becn1, Atg14, and Ambra1 in the PI3K complex also increased in PSCs, indicating that PSCs can more efficiently generate PI3P for autophagosome formation (Figure 2c) . Almost all major genes involved the ATG9 cycling system, with the exception of Atg9a, Wipi1, and Vmp1 that increased expression, suggesting that PCS have a more efficient autophagosome recycling system than somatic cells (Figure 2d ). This result is in agreement with the TEM assays showing that chloroquine can induce a significantly higher rate of autophagosome accumulation in PSCs than in MEFs (Figures 1c and d) . Finally, expression of most core molecular machinery genes involved in both ATG12-ATG5 and LC3-PE conjugation systems was significantly upregulated in PSCs compared with somatic fibroblasts, such that PSCs likely have more efficient isolation membrane elongation and/or closure (Figures 2e and f) . Accordingly, the protein levels produced by core molecular machinery genes were also increased in PSCs compared with MEFs as indicated by enhanced expression of Ulk1, Beclin1, Atg5, Atg3, and LC3 ( Figure 2g and Supplementary Figure S1a) . Collectively, these data suggest that PSCs are equipped with a substantial autophagy infrastructure that is maintained by enhanced expression of core molecular autophagy machinery genes.
To further confirm the correlation between core molecular machinery gene expression and autophagic flux, we established stable ESC lines harboring DOX-inducible siRNA targeting Ulk1, Beclin1, or Atg5 (the siRNA sequences are listed in Supplementary Table S3-4). We found that attenuating the expression of autophagy genes dramatically compromised autophagic flux in ESCs (Supplementary Figure S2d) . These data support the assumption that high autophagic flux in PSCs is indeed maintained by a substantial autophagic infrastructure. Correspondingly, the expression of autophagy core molecular machinery genes declined together with autophagic flux during embryonic body (EB) differentiation (Figures 2h and I and Supplementary Figure S2e ). Taken together, the enhanced coordinated expression of autophagy core molecular machinery genes ensures a high basal autophagic flux in ESCs.
High autophagic flux maintains ESC identity. To test the function of the high autophagic flux seen in ESCs, we first treated ESCs with different doses of 3-MA and detected their effects on pluripotency. As expected, the autophagic flux was dose-dependently inhibited by 3-MA (Supplementary Figure S3a) . Colony formation and pluripotent gene expression were also inhibited by 3-MA in a dose-dependent manner ( Supplementary Figures S3b-d ). An EB differentiation assay showed that 3-MA treatments were associated with defective endoderm differentiation (Supplementary (Figures 3f and g ). Mutations in the membrane-curvature-sensing domain of ATG3 result in defective autophagosome formation. 27 To further confirm that the compromised self-renewal and pluripotency of Atg3 +/ − and Atg3 − / − ESCs resulted from impaired autophagic flux, gain-of-function assays were performed by overexpressing either wild-type Atg3 or the lipidation-deficient mutant Atg3 V8D in Atg3 +/ − and Atg3 Figure S4c) . We found that gain expression of wild-type Atg3 but not Atg3 V8D in Atg3 +/ − and Atg3 − / − ESCs restored the decreased autophagic flux and mitigated the defective self-renewal and pluripotency (Figures 3b, c , and e and Supplementary Figure S4d) . Taken together, these data support that a high autophagic flux guards ESC identity. FOXO1 drives an autophagy machinery gene program to maintain high autophagic flux. We next aimed to characterize the molecular mechanisms that control coordinated increases in autophagy core machinery gene expression that maintain the high autophagic flux. Using the g: profiler tool 28, 29 we found that genes encoding the autophagy core molecular machinery tend to have a coordinated gene expression program (Supplementary Figure S5a) . Table S2 ). This consensus sequence is in accordance with the conserved binding domain of the forkhead family of transcription factors (FOXOs).
FOXO1 and FOXO3 are reported to trigger an autophagy core molecular machinery gene program in somatic cells. 30 To determine which FOXOs coordinate the autophagy gene program in ESCs, we knocked out Foxo1 and Foxo3 by CRISPR/Cas9 (Supplementary Figure S6) . Figures S7a-d) . Thus, these results suggest that Foxo1 regulates expression of core molecular machinery genes that maintain autophagic flux in ESCs. To further test whether autophagy core molecular machinery genes are direct targets of FOXO1, we performed chromatin immunoprecipitation (ChIP) analysis on ESCs using an antibody specific to FOXO1. The ChIP results demonstrated that FOXO1 indeed directly binds to autophagy machinery gene promoters (Figure 4d ).
FOXO1 is a forkhead transcription factor that carries a winged helix DNA-binding domain known as a forkhead box. 30 To further confirm that the impaired autophagy machinery gene expression in Foxo1
− / − ESCs is directly caused by the loss of Foxo1 transcriptional activity, a gain-of-function assay was performed by introducing a Foxo1 expression vector into Foxo1 − / − ESCs. We established stable Foxo1 − / − ESC lines carrying an empty vector, wild-type Foxo1, or a DNA-binding deficient Foxo1 DB mutant (Supplementary Figure S7e) . 31 As expected, autophagy gene expression was restored only in Foxo1 − / − stable ESC lines carrying wild-type Foxo1 but not those with the empty vector or the Foxo1 DB mutant (Supplementary Figures S7f and g ). These results support that the autophagy core molecular machinery genes are directly regulated by Foxo1. Correspondingly, the decreased autophagic flux was rescued in Foxo1 − / − stable ESCs expressing wild-type Foxo1 (Supplementary Figure S7h) .
Collectively, these data demonstrate that FOXO1 drives an autophagy core molecular machinery gene program to maintain the high autophagic flux seen in ESCs.
FOXO1 regulates self-renewal and pluripotency of ESCs. We next investigated whether FOXO1 regulates ESC identity. Both Foxo1 and Foxo3 were highly expressed in ESCs, but loss of FOXO1 but not FOXO3 in ESCs significantly decreased the clonogenic survival rate, suggesting that Foxo1 is pivotal for ESC self-renewal (Figure 4b and Supplementary Figures S8a and b) . Expression of pluripotent genes in Foxo1 − / − but not Foxo3 − / − ESCs was also significantly decreased, indicating that the loss of FOXO1 compromised ESC pluripotency (Supplementary Figures S8c  and d) Figure S8g) . Together, these data indicate that FOXO1 regulates self-renewal and pluripotency by coordinating the autophagy core molecular machinery gene program that maintains high autophagic flux.
Discussion
ESCs are immortal in culture and have a high proliferation rate with a short G1 phase. Proliferating cells require not only energy (ATP) and reducing cofactors (NADH), but also building blocks to replicate macromolecular components during each cell cycle passage. [32] [33] [34] Recent studies showed that increased proteasome activity is an intrinsic characteristic of human ESCs and proposed that human ESCs use enhanced proteasome activity to maintain an intact proteome for ESC self-renewal and pluripotency. 35 In contrast, we demonstrate that ESCs harness high autophagic flux to guard their self-renewal and pluripotency capacity. FOXO1 is a master regulator that coordinates the high expression of autophagy core molecular machinery genes in ESCs to maintain their high autophagic flux. We propose that high autophagic flux driven by FOXO1 protects stemness of ESC through efficient generation of molecular building blocks for use in rapid cell proliferation and/or quick removal of damaged organelles and aggregated proteins that avoid oxidative damage to the genome. Consistent with this hypothesis, Atg5 deletion has been shown to compromise degradation of long-lived proteins, 36 and lack of Atg3-dependent autophagy removal results in accumulation of abnormal mitochondria, increased ROS production, and defective ATP generation in ESCs. 18 High autophagic flux guarding ESC identity is regulated by FOXO1 P Liu et al Although accurate regulation of autophagy by nutrientresponsive kinases is well defined, long-term regulation of autophagy at transcriptional level is poorly understood. 2, 3, 37 Recent studies suggest that transcriptional regulation of autophagic genes is one of the most important molecular mechanisms for functional regulation of autophagy in differentiated cells. In support of this assumption, some studies have identified several transcription factors like TFEB, GATA1, and FOXO3 as positive and ZKSCAN3 as negative master regulators to coordinately modulate a panel of autophagic gene expression in response to distinct stresses. [38] [39] [40] [41] Meanwhile, other studies have found that activation of nuclear receptor farnesoid X receptor (FXR) can inhibit autophagy through downregulation of autophagic gene expression. 42, 43 These studies underline the functional importance of transcriptional regulation of autophagy. In contrast, we have identified that enhanced autophagy molecular machinery, which is transcriptionally regulated by FOXO1, endows ESCs with a powerful autophagic flux to maintain their function integrity. In this point, the finding highlights the transcriptional regulation of autophagy as a critical molecular mechanism to guard cellular identity in pluripotent stem cells.
FOXO transcription factors function as master regulators to control cellular homeostasis in multiple biological processes, whose activity can be inhibited by insulin and growth factor signaling. 30 The mammalian FOXO family, which comprises four members FOXO1, FOXO3, FOXO4, and FOXO6, shows differential but overlapping expression throughout the organism, indicating their functional specificity and diversity. 44 In muscle and cardiomyocyte cells, FOXO3 is identified to regulate autophagy in response to starvation through directly upregulating expression of autophagic genes. 38, 45, 46 In adult stem cells like hematopoietic stem cell (HSC), FOXO3 has also been found to direct a protective autophagic gene expression program for HSC self-renewal and maintenance of HSC pool. 9 In contrast, we have identified that FOXO1 drives a high autophagic flux by coordinating autophagic gene program to maintain ESC identity. These data support the hypothesis that different FOXO family members bind to promoters of target genes with distinct affinities to facilitate their subtle functional division in differential biology process. 44 Most interestingly, a recent study found FOXO1 can regulate ESC pluripotency by direct targeting Oct4 and Sox2. 47 These results suggest that FOXO1 regulates ESC identity by directly targeting both pluripotent genes and autophagic genes, highlighting a novel elaborate autophagy regulation mechanism in ESCs.
In conclusion, our findings define a previously uncharacterized role and mechanism of autophagy in ESC identity regulation, and offer new insights into the current understanding of pluripotency regulation. In addition, this discovery subverts the traditional hypothesis that autophagy is required for nondividing or differentiated cells rather than rapidly proliferating cells, and highlights a pivotal function of autophagy in fast proliferation ESCs.
Materials and Methods
Mice, cell culture, and reagents. Atg3 +/ − mice were purchased from Riken (RBRC02761, Tsukuba, Japan). All protocols used in experiments involving animals were approved by the institutional animal care committee. B6/MEFs were isolated from embryonic day 13.5 (E13.5 d) mice and used within three generations. MEF and HEK293T cells were maintained in DMEM high glucose with 10% fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate, and 1% penicillin/ streptomycin. B6 Atg3
+/ − , and Atg3 − / − ES cell lines were isolated from E3.5 d mice and cultured on feeder layers for 5 d and then routinely passaged. All ESCs and iPSCs were maintained in knockout DMEM with 15% fetal bovine serum, 2 mM glutamine, 1 mM sodium pyruvate, 0.1 mM nonessential amino acids, 1% penicillin/streptomycin, 0.055 mM β-mercaptoethanol, and 1000 U/ml leukemia inhibitory factor (Millipore, Darmstadt, Germany) as previously reported. 48, 49 All cell culture reagents were purchased from Gibco (Carlsbad, CA, USA) unless indicated. Rapamycin, 3-MA, Baf-A1, chloroquine (CQ), and doxycycline (Dox) were purchased from Sigma (St. Louis, MO, USA).
Generation of stable ESC lines. Tetracycline repressor protein (TetR) and full-length mouse ATG3 and FOXO1 cDNA were cloned into pCDH-CAG-RFP lentiviral expression vectors, and various mutations were generated by overlap-PCR using the primers listed in Supplementary Table S3-2. Lentiviral particles were produced by calcium phosphate-mediated cotransfection of HEK293T cells with psPAX2 and pMD2.G plasmids. Supernatants containing the lentiviral particles were collected 48 h after transfections. Mouse ESCs were infected by incubation with lentivirus-containing supernatants for 24 h. After trypsinization, infected ESCs were subcultured at a low density on CF1 MEF feeder layers. After culturing for 6 days, RFP-positive single colonies were picked and cultured normally.
Generation of Foxo1 and Foxo3 knockout ESCs. Foxo1 and Foxo3 knockout ESC lines were generated using a CRISPR-Cas9 system. Briefly, optimal Foxo1 and Foxo3 sgRNA oligonucleotides were cloned into the px330 vector, and 30 μg sgRNA plasmids were electrophoretically transferred to B6/ES cells. After transformation, ESCs were plated at a low density on CF1 MEF feeder layers. Single colonies were picked, cultured, and genotyped by RFLP. Additional sequencing and western blotting was performed to confirm the presence of mutations in the colonies.
Western blotting. Cells were lysed on ice in RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% sodium deoxycholate, 1% Nonidet P-40, 5 mM EGTA, 2 mM EDTA, 10 mM NaF) for 30 min and a protease inhibitor cocktail (04693116001, Roche, Mannheim, Germany) and 1 mM PMSF (ST506, Beyotime, Shanghai, China) was added. The lysates were mixed with loading buffer, boiled, centrifuged, and subjected to SDS-PAGE electrophoresis before transfer to PVDF membranes (Millipore). After blocking with 5% non-fat milk in TBST ( Transmission electron microscopy. For TEM, MEFs and PSCs were fixed with 2.5% glutaraldehyde at 4°C for at least 2 h followed by postfixation in 2% osmium tetroxide (OsO4) for 2 h. After a graded-ethanol serial dehydration, the samples were embedded in epoxy resins. Ultrathin sections (70 nm) were prepared with a diamond knife on an ultramicrotome (Leica EM UC6, Vienna, Austria) and collected on copper grids. Sections were then stained with uranyl acetate and lead citrate, and observed with a Hitachi H-7650B TEM (Hitachi, Tokyo, Japan) operating at 80 kV.
Long-lived protein degradation assay. MEFs and PSCs were labeled for 24 h with 0.2 μCi/ml L-[
14 C]valine. The cells were then washed three times with PBS to remove unincorporated radioisotopes, and incubated with 10 mM unlabeled L-valine in complete growth medium for 1 h (prechase period). After the prechase step, cells were incubated for the designated times in either complete growth medium or EBSS containing 10 mM unlabeled valine with or without 10 mM 3-MA (chase period). After the chase step, proteins from the medium and cells were precipitated separately with 10% (w/v) TCA (overnight, 4°C). The TCA-precipitated fractions were centrifuged (600 × g, 20 min, RT) and redissolved in 1 ml 0.2 N NaOH. Finally, the radioactivity was determined by liquid scintillation counting, and the rate of degradation of long-lived proteins was calculated by determining the ratio between TCA-precipitated radioactivity recovered from the medium and TCA-precipitated radioactivity from the medium and cells.
Real-time PCR. Total RNA was extracted from samples with an RNeasy Mini Kit (Qiagen, Valencia, CA, USA). Approximately 1-2 μg total RNA was reversetranscribed into cDNA using the SuperScript III First-Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). qPCR was performed with GoTaq qPCR Master Mix (Promega, Madison, WI, USA) and a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA); all samples were analyzed in duplicate and normalized to β-actin. The primers used are listed in Supplementary Table S3-1.
Clonogenic survival assay. A clonogenic survival assay was performed as previously described. 18 In brief, mouse ESCs were trypsinized into single cells and seeded into six-well plates with a thin feeder layer at a density of 1 × 10 3 per well for further culture. After 7 days of culture, ES colonies were stained with a BCIP/NBT Alkaline Phosphatase Color Development Kit (Beyotime, Shanghai, China) according to the manufacturer's instructions. AP-positive ES colonies in each well were then counted and photographed.
EB formation assay. Mouse ESCs were dissociated as clusters with 0.05% trypsin-EDTA, seeded in bacterial-grade 60 mm dishes, and cultured with MEF culture medium without LIF. The medium was changed every other day. EBs were collected after 0, 3, 6, or 9 days and then used for further analysis.
Teratoma formation assay. Trypsinized mouse ESCs (1-2 × 10 6 ) were subcutaneously injected into 6-week-old NOD SCID mice (Vital River, Beijing, china). After 4 to 6 weeks, the resulting tumors were surgically removed, weighed, and fixed in 4% paraformaldehyde overnight and embedded in paraffin. Sections were prepared and stained with hematoxylin and eosin for histological examination as previously reported. 50 ChIP assay. ChIP assays were performed using a Magna ChIP A/G ChIP Kit (17-10085, Millipore) according to the manufacturer's protocol. Briefly, 1 × 10 7 B6/ ES cells were fixed with 1% paraformaldehyde, washed, resuspended in lysis buffer, and sonicated. Lysates containing soluble chromatin were prepared and incubated with antibodies specific to FOXO1 (ab39670, Abcam) and control rabbit IgG (sc-2027, Santa Cruz). After the protein/DNA complexes were eluted, the crosslinking was reversed and the purified. The specific DNA fragments were quantitated by qRT-PCR and normalized to input. ChIP PCR analysis primer sets were designed to cover the FOXO binding region of the promoter region in selected autophagy-related genes and are listed in Supplementary Table S3-3.
Cell proliferation and apoptosis assay. CFSE-labeled live cells were used to quantify cell proliferation in vitro. Briefly, 1 × 10 6 ES cells were incubated with 5 μM CFSE (21888, Sigma) for 15 min at 37°C, and then washed three times. After CFSE labeling, 2 × 10 5 cells were seeded into a 6-well plate for further culture. Cells were then harvested at the indicated time points and analyzed by flow cytometry. For apoptosis detection, an Alexa Fluor 488 Annexin V/Dead Cell Apoptosis Kit (Invitrogen) was used according to the manufacturer's instructions. Briefly, cells were washed with PBS and resuspended in binding buffer. The cells were then incubated with annexin-V-FITC and propidium iodide (PI) for 20 min at RT, and subsequently analyzed by flow cytometry. Cells that were annexin-V negative and PI negative were counted as viable cells, and those that were annexin-V positive and PI negative were counted as apoptotic cells.
Expression correlation and sequence alignment analysis. Expression correlation analysis was performed using the g: profiler tool as previously described. 28, 29 Sequence alignment analysis was performed to identify transcription factor binding sites in the regulatory regions of autophagy-related genes as previously described. 51 Statistical analysis. All data were derived from multiple independent experiments rather than technical replicates. Most were presented as mean ± S.D. Each exact n value is stated in the corresponding figure legend. Statistical significance was calculated using the two-tailed Student's t-test between the indicated groups, and P-values of o0.05 were considered statistically significant (*Po0.05, **Po0.01, ***Po0.001).
